Skip to content

Innovative application of dexmedetomidine combined with scopolamine in the clinical treatment of intractable insomnia

Innovative application of dexmedetomidine combined with scopolamine in the clinical treatment of intractable insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062531
Enrollment
Unknown
Registered
2022-08-10
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable insomnia

Interventions

3:dexmedetomidine+scopolamine4ug/kg
4:dexmedetomidine+scopolamine8ug/kg
5:dexmedetomidine+scopolamine12ug/kg

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Both male and female, aged from 18 to 65 years, with a course of disease of 6 months or more; Insomnia severity index (ISI) >15 points (2) ASA is classified as grade I ~ II; (3) Pittsburgh sleep quality index (PSQI) score >7; (4) In the past, after more than two different types of drug system treatment, there were still insomnia symptoms;

Exclusion criteria

Exclusion criteria: (1) Have a history of serious physical and mental diseases; (2) History of severe head trauma, history of epilepsy and abnormal electroencephalogram; (3) Previous allergic history of scopolamine, dexmedetomidine and propofol; Glaucoma, organic pyloric stenosis or paralytic intestinal obstruction; (4) Unable to understand the contents of relevant scales; (5) Pregnancy plan during pregnancy, lactation and short term; (6) Low blood volume and severe heart block

Design outcomes

Primary

MeasureTime frame
5-HT;

Secondary

MeasureTime frame
PSQI score;

Countries

China

Contacts

Public ContactWenyuan Wang

Zhejiang Provincial People's Hospital

Neuro-anesth@hotmail.com135 8808 3716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026